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ABSTRACT: DNA origami nanostructures are regarded as powerful and
versatile vehicles for targeted drug delivery. So far, DNA origami-based drug
delivery strategies mostly use intercalation of the therapeutic molecules
between the base pairs of the DNA origami’s double helices for drug loading.
The binding of nonintercalating drugs to DNA origami nanostructures,
however, is less studied. Therefore, in this work, we investigate the
interaction of the drug methylene blue (MB) with different DNA origami
nanostructures under conditions that result in minor groove binding. We
observe a noticeable effect of DNA origami superstructure on the binding
affinity of MB. In particular, non-B topologies as for instance found in designs using the square lattice with 10.67 bp/turn may
result in reduced binding affinity because groove binding efficiency depends on groove dimensions. Also, mechanically flexible
DNA origami shapes that are prone to structural fluctuations may exhibit reduced groove binding, even though they are based
on the honeycomb lattice with 10.5 bp/turn. This can be attributed to the induction of transient over- and underwound DNA
topologies by thermal fluctuations. These issues should thus be considered when designing DNA origami nanostructures for
drug delivery applications that employ groove-binding drugs.
■ INTRODUCTION
During the last three decades, the field of structural DNA
nanotechnology has developed a variety of techniques to
assemble DNA into increasingly complex two-dimensional
(2D) and three-dimensional (3D) nanostructures.1−3 Cur-
rently, DNA nanostructures and especially DNA origami4,5 are
widely investigated with regard to their applicability in fields as
diverse as nanoelectronics,6−10 molecular sensing,11−14 and
drug delivery.15−26 For the latter application, drug loading of
the DNA origami delivery systems has been achieved mostly
via intercalation between the base pairs of the DNA origami’s
double helices.16−19,23,25,26 Intercalation induces unwinding of
the double helices and may therefore lead to structural
distortions of the DNA origami nanostructures.16,27 By
employing DNA origami designs with deliberately under-
wound double helices, however, intercalator loading of the
DNA origami can be enhanced.16,28
The interaction of DNA origami with other chemical species
that undergo nonintercalative binding to DNA is less studied.
Opherden et al. investigated Mg2+ and Eu3+ coordination of
two different DNA origami nanostructures, that is, 2D triangles
and 3D six-helix bundles (6HBs).29 By employing a variety of
spectroscopic techniques, a superstructure-specific geometry of
Eu3+-binding sites was revealed in the two DNA origami
designs that furthermore deviates from that of genomic double-
stranded DNA (dsDNA).
In this work, we investigate the binding of the drug
methylene blue (MB) to different 2D and 3D DNA origami
nanostructures under conditions favoring minor groove
binding and observe a strong dependence on DNA origami
superstructure. MB is a fluorescent azine dye that is widely
used as an optical and electrochemical probe molecule in the
study of DNA-based systems and reactions.30−33 In clinical
practice, MB has been used extensively as a therapeutic agent
to treat numerous diseases, including malaria and methemo-
globinemia.34,35 More recently, MB has been rediscovered as a
photosensitizer for the photodynamic therapy of various viral,
bacterial, and fungal infections, as well as cancers.36−45
Consequently, also the delivery and controlled release of MB
by various carrier systems has received significant attention in
recent years.46−53
■ RESULTS AND DISCUSSION
MB can interact with dsDNA via different binding modes. At
low salt concentrations, intercalation into the G−C base pairs
is favored, whereas at the high salt concentrations typically
employed in DNA origami experiments, for example, 10 mM
MgCl2 as used in the following experiments, a transition to
nonintercalative binding occurs.54−57 Irrespective of the
binding mode, however, interaction of MB with DNA is in
general accompanied by a decrease in its absorption at 668
nm.57−59
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In order to elucidate the nature of this nonintercalative
binding mode, UV−vis absorbance spectra of MB with and
without genomic dsDNA from salmon testes were recorded at
different ionic strengths. This dsDNA has a GC content of
41% and is thus comparable to the fully hybridized M13mp18-
based DNA origami scaffold with a GC content of 42%. As can
be seen in the spectra presented in Figure 1a, the absorbance at
668 nm clearly decreases upon addition of dsDNA, both in
water and in 1× TAE (Tris base, acetic acid, and ethyl-
enediaminetetraacetic acid) buffer supplemented with 10 mM
MgCl2. In water, this hypochromicity is accompanied by a
significant red shift of the absorbance peak that results in a
crossing of both spectral signatures at a wavelength of about
680 nm. In TAE/MgCl2 buffer, however, this shift is absent,
indicating the nonintercalative binding of MB, which is in
agreement with previous reports.58,59
In order to identify the nonintercalative binding mode of
MB, competition assays were performed, employing spermi-
dine and netropsin. While spermidine can bind to both the
minor and major grooves,60,61 netropsin is a potent minor
groove binder.62,63 Depending on the binding modes of MB
and the competing groove binder, addition of a large excess of
these groove binders will result in its displacement from the
minor groove, the major groove, or both, and thereby reverse
the hypochromicity observed upon MB binding to the dsDNA.
Indeed, as can be seen in Figure 1b, addition of both groove
binders results in a drastic increase in MB absorbance, which
almost reaches the value of free MB. This verifies the binding
of MB to the minor groove of dsDNA under the current buffer
conditions, which also agrees with previous theoretical
predictions.64
Next, we set out to investigate the interaction of MB with a
selection of representative DNA origami nanostructures (see
Figure 2). In particular, we chose two 3D DNA origami
nanostructures, that is, 6HBs65 and 60-helix bundles
(60HBs).66 The 6HBs have previously been found to have
an extraordinarily high structural stability under physiological
conditions, whereas more complex 3D structures such as the
60HB are typically less stable.67,68 Furthermore, we also
selected three differently shaped 2D DNA origami. The Z
shape69 is also designed on the honeycomb lattice and features
a chiral shape that may serve as an indicator for visualizing
MB-binding-induced structural distortions by atomic force
microscopy (AFM).27 The Rothemund triangle,4 on the other
hand, has previously been identified as a potent drug delivery
vehicle in vivo.18 It is designed on the square lattice and
appears highly strained (see the corresponding CanDo70,71
simulation in Figure 2). In order to evaluate the effect of such
strain on MB binding, we have also evaluated a more relaxed
DNA origami structure in the form of a bow tie that is
designed on the same lattice but twist-corrected.69 These DNA
origami nanostructures are characterized by AFM in Figure 2,
both directly after assembly and after subsequent exposure to
20 μMMB. Obviously, all DNA origami nanostructures remain
intact upon MB exposure. Furthermore, no major structural
distortions induced by MB binding can be observed by AFM.
This is in agreement with the minor groove binding of MB,
which does not require any major structural alterations of the
DNA helices.54,55,64,72 Intercalators, on the other hand, may
induce unwinding of the helices and thereby twisting of the
DNA origami.16,27,28 Such a twisting should be visible at least
for the Z-shaped DNA origami.27
The binding of MB to these DNA origami nanostructures
was investigated by UV−vis spectroscopy. In addition to the
DNA origami, we also used synthetic dsDNA (15 bp) with a
GC content close to that of the M13 scaffold (40%) as a
reference. All the UV−vis spectra shown in Figure 3a were
characterized by a decrease in the absorbance of MB at 668 nm
with increasing DNA concentration. As in the case of genomic
dsDNA, no bathochromic shift of the absorption peak is
observed, indicating the binding of MB to the minor groove.
The normalized absorbance values shown in Figure 3b are
found to saturate at high DNA concentrations, indicating that
at these concentrations, all MB in solution is DNA-bound. For
all DNA origami nanostructures investigated here, saturation
occurs at phosphate concentrations between 35 and 55 μM
and with different saturation values of the absorbance. Also,
the obtained loading efficiencies differ significantly for the
different DNA origami nanostructures (see Table S1 for base
pair contents) and range from about 5700 MB molecules per
DNA origami for the 60HB to about 7400 for the bow tie (see
Table S1).
The differences in the MB−DNA interaction observed in
Figure 3a,b were assessed more quantitatively by converting
the concentration-dependent absorbance values at 668 nm into
binding isotherms (see Figure 3c) as described by Zhang and
Figure 1. (a) UV−vis absorbance spectra of 20 μM MB with and
without genomic dsDNA from salmon testes in water and MgCl2-
containing TAE buffer. DNA concentrations were 13 μM (water) and
11 μM (TAE + 10 mM MgCl2) in phosphates. In order to enhance
the signal-to-noise ratio and detect even small bathochromic shifts,
the shown spectra have been averaged over 10 individual absorbance
measurements. Individual spectra can be found in the Supporting
Information. (b) UV−vis spectra of the competition between 20 μM
MB and 500 μM spermidine (left) and netropsin (right), respectively,
in 1× TAE buffer supplemented with 10 mM MgCl2. The spectra of
the spermidine-containing samples exhibited a broad background
which has been subtracted in the above plot. The concentration of the
genomic dsDNA was 308 μM in phosphates.
ACS Omega Article
DOI: 10.1021/acsomega.8b00934
ACS Omega 2018, 3, 9441−9448
9442
Tang.58 From the linear fits to the data shown in Figure 3c,
dissociation constants Kd can be calculated as the ratio of
intercept and slope.58 This approach is frequently employed
for the quantitative investigation of the interaction of DNA
with both intercalators58,73 and groove binders.74,75
All the determined Kd values are compared in Figure 4.
Obviously, DNA origami 6HBs present a Kd value virtually
identical to that of synthetic dsDNA with the same GC
content. This is to be expected because the 6HBs have been
designed on a honeycomb lattice with 10.5 bp per helical turn
and should thus exhibit a DNA topology close to the canonical
B-form. The same argument of DNA topology also holds true
for the 60HB, which indeed has a similar Kd as the 6HB and
the dsDNA. Although in such compact 3D DNA origami
nanostructures, access of MB to the inner helices may be
restricted because of the shielding by the outer helices, this
effect appears to be of minor importance in the 60HB.
Such geometric effects, however, should be entirely absent in
structures that consist just of a single honeycomb “unit cell”
such as the 6HB or in objects that are purely two-dimensional.
The latter is true for the Z-shaped 2D DNA origami that was
constructed using the honeycomb lattice and is thus designed
to exhibit 10.5 bp/turn just as the 6HB and the 60HB.
Surprisingly, however, the Kd determined for the Z-shaped
DNA origami is more than twice as large as those of the 6HB
and the dsDNA (see Figure 4). On the basis of the overlap rule
Figure 2. CanDo70,71 simulations and AFM images (1 × 1 μm2) of 6HBs (height scales 4.5 nm), 60HBs (height scales 12 nm), Z-shaped DNA
origami (height scales 3 nm), triangles (height scales 3 nm), and bow ties (height scales 2 nm) before and after exposure to 20 μM MB. The color
coding in the CanDo simulations indicates the lattice type (redhoneycomb, bluesquare).
Figure 3. (a) Representative UV−vis spectra of 20 μM MB in 1× TAE buffer containing 10 mM MgCl2 and different phosphate concentrations of
dsDNA and different DNA origami nanostructures, respectively. The spectra are normalized to the absorbance at 668 nm in the absence of any
DNA. (b) Representative normalized MB absorbance at 668 nm as a function of phosphate concentration. (c) Corresponding binding isotherms.
The solid red lines in (c) are linear fits to the data that have been used for the determination of Kd values. R
2 values of the fits are given in the plots.
Error bars in (b,c) represent standard deviations obtained by averaging over five individual measurements. For Kd determination, these
concentration-dependent measurements have been repeated at least once (see Methods).
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of standard error bars,76 the difference between the Z shape
and the dsDNA is estimated to be statistically significant with p
< 0.05.
In addition to the honeycomb lattice-based DNA origami,
we have also evaluated MB binding to two 2D DNA origami
nanostructures based on the square lattice.4,69 These structures
are designed with 10.67 bp/turn and thus exhibit DNA
topologies different from the canonical B-form of dsDNA.4
Efficient minor groove binding of MB64,72 and other
molecules77,78 typically requires a tight fit. Therefore, under-
winding of the helices will result not only in an increased
spacing of base pairs but also in a widened minor groove79 and
should thereby reduce the binding affinity of MB. This is in
contrast to the case of intercalation, where underwinding
results in lower Kd values because of easier access to the
widened gaps between base pairs.16,28 In agreement with this
hypothesis, both DNA origami triangles and twist-corrected
bow-tie structures show Kd values slightly higher than that of
dsDNA, although the effect is surprisingly small (see Figure 4).
Of all the DNA origami nanostructures studied in this work,
the Z shape shows the strongest deviation from B-DNA, even
though it is designed on the same honeycomb lattice as the
6HB and the 60HB, both of which show Kd values similar to
dsDNA. We speculate that the high Kd of the Z-shaped DNA
origami is caused by the presence of DNA topologies different
from the canonical B-form. Despite being based on the
honeycomb lattice, such non-B topologies may occur
transiently, that is, resulting from thermal fluctuations. In the
Z-shaped DNA origami, all helices are aligned parallel to its
long axis, including those in the two arms (see Figure 2).
These arms are therefore comparatively floppy and subject to
strong fluctuations. These fluctuations travel from helix to helix
via the crossovers, thereby inducing an oscillatory over- and
underwinding of the helices in the vicinity of the crossovers
(see CanDo70,71 simulations in the Supporting Information).
Because groove binding requires a tight fit, both over- and
underwinding will result in reduced binding and in sum to an
increased Kd. The bow-tie design also features only parallel
helices and could therefore show a similar behavior as the Z
shape. However, because of the intrinsic underwinding of the
helices in the square lattice, fluctuations in the bow tie may
lead even to slightly improved groove binding because of the
occurrence of transient B-form topologies. Note that in the
case of intercalation, such fluctuations will not lead to different
Kd values because here overwinding and underwinding result in
lower and higher binding affinities, respectively, and thus
compensate each other.
■ CONCLUSIONS
In conclusion, we have investigated the interaction of the drug
MB with different DNA origami nanostructures under
conditions that result in binding to the minor groove. The
DNA origami superstructure is found to have a noticeable
influence on the binding efficiency of MB. In particular, non-B
topologies as for instance found in designs using the square
lattice with 10.67 bp/turn may result in reduced binding
affinity. Furthermore, also flexible DNA origami shapes that are
prone to structural fluctuations may exhibit reduced groove
binding because of the induction of transient over- and
underwound DNA topologies. These issues should be
considered when rationally designing DNA origami nanostruc-
tures for drug delivery applications employing groove-binding
drugs.
■ METHODS
Preparation of dsDNA Samples. For the initial experi-
ments addressing the binding mode of MB, lyophilized
genomic dsDNA from salmon testes (Alfa Aesar) was dissolved
at the desired concentration either in high-performance liquid
chromatography (HPLC)-grade water (Carl Roth) or in 1×
TAE (Calbiochem) with 10 mM MgCl2 (Sigma-Aldrich). MB,
spermidine, and netropsin (all Sigma-Aldrich) were added to
achieve the desired concentrations.
For comparison with the DNA origami nanostructures,
synthetic dsDNA was prepared by hybridization of two
complementary oligonucleotides (Metabion) with the sequen-
ces 5′-TTG GAA CAG CAT TGA-3′ and 5′-TCA ATG CTG
TTC CAA-3′. To this end, the readily mixed sample (100 μM
of each strand in 1× TAE with 10 mM MgCl2) was heated to
94 °C in a thermocycler Primus 25 advanced (PEQLAB), kept
at this temperature for 5 min, and cooled down to 20 °C with a
cooling rate of 1.5 °C per minute.
DNA Origami Synthesis and Purification. All DNA
origami nanostructures were fabricated as previously reported
(see below). All structures are based on the 7249 nt long
M13mp18 scaffold (purchased from Tilibit Nanosystems).
• Triangle: the staple sequences (purchased from
Metabion) are taken from the article by Rothemund.4
DNA origami assembly was performed as previously
described.80
• 6HB: the staple sequences (purchased from Metabion)
are taken from the article by Bui et al.65 DNA origami
assembly was performed as previously described.81
• 60HB: the staple sequences and the exact fabrication
protocol (20 nM reactions) can be found in the article
by Linko et al.66 Staple strands were purchased from
IDT.
• Z shape and bow tie: the staple sequences and the exact
fabrication protocol (20 nM reactions) can be found in
the article by Shen et al.69 Staple strands were purchased
from IDT.
After assembly, the DNA origami nanostructures were
purified as described previously80 by spin-filtering (Amicon
Ultra filters from Millipore with 100 kDa molecular weight
cutoff) and washing with 1× TAE supplemented with 10 mM
MgCl2.
Determination of DNA Origami Concentrations. The
concentrations of the DNA origami after purification were
determined by UV−vis absorbance measurements using an
Implen Nanophotometer P330 operated in dsDNA mode.
Figure 4. Determined Kd values for the investigated DNA structures.
Values are presented as averages over n independent concentration
series with the standard error of the mean as error bars (see
Methods).
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Because different DNA origami nanostructures feature differ-
ent numbers of base pairs and unpaired nucleotides, the so-
determined concentration values had to be corrected.
The measured concentration cm is a result of the combined
absorption the single-stranded DNA (ssDNA) and the dsDNA
fractions in the DNA origami. Because the extinction of
ssDNA is about 1.5 times higher than that of dsDNA,82 the
real concentration creal is given by
= × + − ×c x c x c1.5(1 )m real real
Here, x is the fraction of paired bases relative to the total
number of nucleotides (paired and unpaired) in the DNA
origami. The numbers of base pairs and nucleotides of the
DNA origami used in this work are given in Table S1.
UV−Vis Spectroscopy. UV−vis absorbance spectra with a
spectral range from 200 to 800 nm were recorded with an
Implen Nanophotometer P330 equipped with a sub-microliter
cell. The sample volume for each measurement was 2 μL. After
each measurement, the cell was washed at least twice with
HPLC-grade water.
To record the UV−vis spectra of samples with different
DNA concentrations, a 20 μMMB solution in 1× TAE with 10
mM MgCl2 was measured first. Then, a small aliquot of a
DNA-containing solution (80−300 μM in phosphates depend-
ing on the DNA structure, 1× TAE, 10 mM MgCl2, 20 μM
MB) was added to the initial MB solution and mixed well.
After recording the UV−vis spectra of the resulting solution,
the addition and measurement cycle was repeated several times
to record a complete concentration series.
Determination of Kd Values. For the determination of
the dissociation constants, the measured absorption at 668 nm
was averaged over at least five individual measurements at each
DNA concentration in a concentration series, and the resulting
standard deviations were treated as error limits. After
transforming the data according to the protocol of Zhang
and Tang,58 the Kd of each concentration series was
determined from a linear fit to the data with instrumental
weighting of the errors (see below). For each DNA origami,
this determination of Kd has been performed for two to three
independent concentration series. The so-obtained Kd values
for each DNA origami were averaged, and the error limits of
the individual linear fits were used for determining the
standard error of the mean for each Kd value given in Figure
4 via propagation of error (see Table S3).
The binding constant Kd follows from the relation
ε ε ε
[ ]
Δ
=
Δ
[ ] +
Δ
KPho 1
Pho
ap
d
Here, [Pho] refers to the molar concentration of phosphates,
which has been used instead of the concentration of base pairs
in order to account for the different fractions of paired and
unpaired nucleotides in the different DNA origami designs.
Δεap is the difference between the measured extinction
coefficient of the DNA−MB solution, εa, which features both
DNA-bound and free MB and the extinction coefficient of free
MB in a solution without DNA, εf, with
ε ε εΔ = | − |ap a f
Here, εa and εf are determined by dividing the measured
absorbance values by the molar MB concentration, which was
kept constant at 20 μM in all experiments.
Δε represents the difference of the extinction coefficients of
DNA-bound MB, εb, and free MB, εf, that is,
ε ε εΔ = | − |b f
The dissociation constant Kd is then determined by plotting
ε
[ ]
Δ
Pho
ap
versus [Pho] and fitting the data with a linear function. In
this case, the linear fit has a slope of
εΔ
1 and intercepts the y-
axis at
εΔ
Kd . Therefore, dividing the intercept by the slope yields
the binding constant Kd.
AFM Imaging. For AFM imaging, a 5 μL droplet of each
DNA origami sample (10 nM in 1× TAE with 10 mM MgCl2)
with or without 20 μM MB was deposited on a freshly cleaved
mica substrate. After adding 100 μL of 1× TAE with 10 mM
MgCl2 to spread the sample over the whole substrate surface,
the sample was incubated for 5−15 min, subsequently dipped
in HPLC-grade water, and dried in a stream of ultrapure air.
AFM imaging was performed in air using Agilent 5100 AFM in
intermittent contact mode and HQ:NSC18/Al BS cantilevers
from MikroMasch.
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